StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker Stryker by Quarter

Stryker — FDA MAUDE Adverse Event Reports Total (reports)

QuarterlyAnnualMonthly

Stryker Stryker: 2,755 in Q3 2026, up 10.0% from a year earlier.

Latest, Q3 2026
2,755
Period ended Sep 30, 2026
Change on a year earlier
+10.0%
2,505 in Q3 2025
History
51 quarters
Since Q1 2014
Sources
1
U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker

Where the Q3 2026 figure comes from

Source: U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗

Reported in U.S. FDA openFDA Device Adverse Events API.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedStryker — FDA MAUDE Adverse Event Reports Total (reports)Year on yearSource
Q3 2026Sep 30, 20262,755+10.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q2 2026Jun 30, 20261,856-31.1%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q1 2026Mar 31, 20262,037-18.6%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q4 2025Dec 31, 20252,668-4.6%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q3 2025Sep 30, 20252,505-12.4%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q2 2025Jun 30, 20252,693+11.7%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q1 2025Mar 31, 20252,501+4.6%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q4 2024Dec 31, 20242,796+12.9%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q3 2024Sep 30, 20242,858+20.3%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q2 2024Jun 30, 20242,411-17.1%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q1 2024Mar 31, 20242,390-1.4%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q4 2023Dec 31, 20232,477-3.1%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q3 2023Sep 30, 20232,375+8.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q2 2023Jun 30, 20232,910+17.3%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q1 2023Mar 31, 20232,424+15.6%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q4 2022Dec 31, 20222,557+15.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗

Breakdown

What makes up stryker

Cite this data

StockData. (2026). Stryker Stryker, quarterly Q1 2014–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/ext-fda-maude

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.